Skip to main content
Premium Trial:

Request an Annual Quote

One Lambda HLA Software Cleared by US, Canadian Regulators

NEW YORK (GenomeWeb News) – Regulators in the US and Canada have cleared One Lambda's companion software to molecular typing and antibody screening products, the Thermo Fisher Scientific business said late Wednesday.

The US Food and Drug Administration cleared the HLA Fusion Software version 3.0, while Canada's Ministry of Health has also granted the software a Health Canada License.

One Lamba's software is used to help personnel experienced in HLA analysis by suggesting typing and antibody screening results, the company said, adding that HLA Fusion Software version 3.0 is intended as a laboratory aid, not for definitive results.

Thermo Fisher acquired One Lambda, which specializes in transplant diagnostics, in September for $925 million.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.